1477635 Dibenzazepines RESEARCH INSTITUTE FOR MEDICINE & CHEMISTRY Inc 23 Aug 1974 [24 Aug 1973] 40242/73 Heading C2C Compounds of the general formula (RSP1,2/SP=H, alkyl; RSP3/SP = alkyl, optionally substituted, RSP4/SP=H or alkyl, optionally substituted, or NRSP3/SPRSP4/SP=heterocyclic group; the dibenzazepine nucleus optionally carrying one or more substituents selected from halogen, alkyl, alkoxy, alkylthio in position(s) 2, 3, 7 and/or 8 and their acid addition salts are prepared by (a) reacting the 5-unsubstituted compound or an alkali metal derivative thereof with (X=reactive ester radical; RSP7/SP = NRSP3/SPRSP4/SP or substituent convertible into or replaceable by such a group), followed by conversion of RSP7/SP to NRSP3/SPRSP4/SP if necessary, or (b) reducing the corresponding compound containing a keto group in the 1-position of the 5-substituent, optionally followed by salt formation in either case. The starting materials are prepared by reacting a 5 - acyl - 5H - dibenz[b,f]azepiae (obtained by acylation) with trifluoromethyl hypofluorite followed by dehydrofluorination and, if necessary, deacylation. The above compounds are antidepressants, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
展开▼
机译:1477635 Dibenzazepines医药与化学研究所1974年8月23日[1973年8月24日]标题C2C通式为(R 1,2 SP> = H,烷基; R 3 < / SP> =烷基,可选被取代,R 4 SP> = H或烷基,可选被取代,或NR 3 SP> R 4 SP> =杂环基;二苯并ze庚因原子核可通过在以下条件下进行制备:(a)使5个未取代的化合物或(X =反应性酯基; R 7 SP> = NR 3 SP> R 4 SP>或可转化为或可被该基团取代基取代的碱金属衍生物),然后根据需要将R 7 SP>转换为NR 3 SP> R 4 SP>,或者(b)在其中还原含有酮基的相应化合物5位取代基的1位,在两种情况下均可选地随后形成盐。使5-酰基-5H-二苯并[b,f]氮杂环丁烷酯(通过酰化反应)与三氟甲基次萤石反应,然后进行脱氟化氢作用,以及必要时进行脱酰反应,生成红色。上述化合物是抗抑郁药,并且可以以包含它们与载体结合的药物制剂的形式给药。
展开▼